All treatments
Treatment
Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic use (Phase IV)
Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the RSV immune response.
This study looks at how well RSV vaccines work in people with inflammatory rheumatic diseases. We want to see if their anti-rheumatic medicines affect how their body responds to the vaccine and creates protection against the RSV virus.
For: Inflammatory rheumatic diseaseSweden - AuthorisedTherapeutic confirmatory (Phase III)
Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV immunisation adaptive platform trial
Researchers are looking into new ways to protect babies from a common chest infection called RSV. This study is testing special medicines designed to prevent RSV in infants. It aims to see how well these work and keep babies healthy.
For: Respiratory Syncytial Virus (RSV)Belgium · Netherlands